Shares of Hologic Inc. HOLX slipped 1.46% to $63.53 Wednesday, on what proved to be an all-around rough trading session for ...
Hologic Inc. closed 23.86% short of its 52-week high of $84.67, which the company reached on August 9th.
Fintel reports that on February 3, 2025, Needham downgraded their outlook for Hologic (NasdaqGS:HOLX) from Buy to Hold.
Andrew Cooper; Analyst; Raymond James & Associates, Inc. Good afternoon and welcome to the Hologic's first quarter fiscal 2025 earnings conference call. My name is Lisa and I'm your operator for ...
Marlborough, Massachusetts-based Hologic, Inc. (HOLX) develops, manufactures, and supplies diagnostics products, imaging ...
In this article, we are going to take a look at where Hologic, Inc. (NASDAQ:HOLX) stands against other firms that hit hard in Thursday’s trading. Shares of 10 companies were hit hard on Thursday ...
Marlborough, Massachusetts-based Hologic, Inc. (HOLX) develops, manufactures, and supplies diagnostics products, imaging systems, and surgical products for women's health through early detection ...
Hologic lowered its fiscal 2025 revenue forecast, citing weakness in sales of its breast health products, sending the company's shares down 5% after the bell on Wednesday.
Q1 2025 Earnings Conference Call February 5, 2025 4:30 PM ETCompany ParticipantsMike Watts - Corporate Vice President, ...
Raymond James lowered the firm’s price target on Hologic (HOLX) to $90 from $95 and keeps an Outperform rating on the shares. Hologic’s print ...
Leerink downgraded Hologic (HOLX) to Market Perform from Outperform with a price target of $75, down from $80, following the fiscal Q1 report.